- In full:
- Elias Adam Zerhouni
- Born:
- April 1, 1951, Nedroma, Algeria (age 75)
Elias Zerhouni
-
Who is Elias Zerhouni?
Elias Zerhouni, born in Nedroma, Algeria, on April 1, 1951, is an Algerian-American radiologist. He became the 15th director of the U.S. National Institutes of Health (NIH), serving from 2002 to 2008.
After earning Algerian and French baccalaureates, Zerhouni studied at the University of Algiers School of Medicine. He moved to the United States in 1975 and secured a radiology residency at Johns Hopkins University School of Medicine. His research in computed tomography led to a technique for identifying lung nodules. Zerhouni invented revolutionary MRI cardiac-tagging technology and helped devise an image-directed replacement for invasive methods for breast cancer diagnosis.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What is a radiologist?
Radiology is a branch of medicine using radiation for diagnosing and treating disease. It uses X-rays, gamma rays, radioactive isotopes for organ scanning, nonionizing radiation, ultrasound waves, and nuclear magnetic resonance.
Elias Zerhouni (born in Algeria, 1951) is an American radiologist who served as the 15th director of the U.S. National Institutes of Health (NIH) from 2002 to 2008. At Johns Hopkins, Zerhouni's research on computed tomography led to a technique enabling radiologists to identify benign and malignant nodules in the lungs. Later, as director of the MRI division, he helped devise an image-directed replacement for invasive methods for breast cancer diagnosis.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What are some of Elias Zerhouniās major achievements?
Elias Zerhouni, an Algerian-born American radiologist, directed the National Institutes of Health (NIH) from 2002 to 2008. His research in computed tomography led to a technique for identifying benign and malignant lung nodules. He also invented revolutionary MRI cardiac-tagging technology and helped devise an image-directed replacement for invasive methods for breast cancer diagnosis. As NIH director, Zerhouni advocated for more research to achieve a "quantum leap" in medical discoveries and helped establish the Institute for Cell Engineering at Johns Hopkins.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What role did Elias Zerhouni have at the National Institutes of Health (NIH)?
Elias Zerhouni, an Algerian-born American radiologist, served as the 15th director of the U.S. National Institutes of Health (NIH) from 2002 to 2008. Appointed by President George W. Bush in 2002, Zerhouni was chosen after an extensive search. As director, he advocated for increased medical research to achieve significant advancements in medical discoveries, aiming to control rising healthcare costs. Additionally, Zerhouni contributed to the establishment of the Institute for Cell Engineering at Johns Hopkins, where researchers conducted pioneering embryonic stem cell research. He stepped down from his role as NIH director in October 2008.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How did Elias Zerhouni contribute to medical research and health care?
Elias Zerhouni, an Algerian-born American radiologist, significantly contributed to medical research and healthcare. His research on computed tomography led to a technique for identifying benign and malignant nodules in the lungs. As codirector of a new magnetic resonance imaging (MRI) division at Johns Hopkins, he invented revolutionary MRI cardiac-tagging technology and helped devise an image-directed replacement for invasive methods for breast cancer diagnosis.
As the director of the NIH from 2002 to 2008, Zerhouni called for more research to effect a quantum leap in medical discoveries, which he said was the most effective way to control the countryās ever-increasing health care costs. He also helped create the Institute for Cell Engineering at Johns Hopkins.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
Why is Elias Zerhouni considered an influential figure in science and medicine?
Elias Zerhouni is an influential figure in science and medicine due to his pioneering work in radiology and his leadership at the National Institutes of Health (NIH). His research at Johns Hopkins led to a computed tomography technique for identifying lung nodules. Zerhouni also invented revolutionary MRI cardiac-tagging technology and helped devise an image-directed replacement for invasive methods of breast cancer diagnosis.
As the director of the NIH from 2002 to 2008, he advocated for a "quantum leap" in medical discoveries to control rising healthcare costs. Zerhouni's administrative skills and ability to find solutions were also recognized by his peers.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.
Elias Zerhouni (born April 1, 1951, Nedroma, Algeria) is an Algerian-born American radiologist who served as the 15th director of the U.S. National Institutes of Health (NIH) from 2002 to 2008.
Zerhouni, who had seven siblings, was born in a small village in western Algeria. His father was a math professor. In 1953 the family moved to the city of Algiers, where Zerhouni earned Algerian and French baccalaureates before studying at the University of Algiers School of Medicine. Influenced by his maternal uncle, a well-known radiologist, Zerhouni chose radiology as his field, and after receiving his medical degree in 1975, he moved to the United States. Barely able to speak English, Zerhouni nonetheless earned a position as radiology resident at Johns Hopkins University School of Medicine, rising to chief resident in 1978 and joining the faculty a short time later. At Johns Hopkins Zerhouni participated in research on computed tomography that led to a technique enabling radiologists to identify benign and malignant nodules in the lungs.
In 1981 Zerhouni became vice-chairman of the radiology department at Eastern Virginia Medical School, where he pioneered further scanning techniques. He returned to Johns Hopkins in 1985 and, as codirector of a new magnetic resonance imaging (MRI) division, invented a revolutionary MRI cardiac-tagging technology and later, as director of the MRI division, helped devise an image-directed replacement for invasive methods for breast cancer diagnosis. Zerhouni served as a consultant to the White House in 1985 and the World Health Organization in 1988. In 1990 he became a naturalized U.S. citizen. Zerhouni rose to the post of chairman of the department of radiology at Johns Hopkins in 1992 and to executive vice dean in 1996. He became a member of the Institute of Medicine, an arm of the National Research Council complex, in 2000.
Peers hailed Zerhouni as a solid administrator who had the ability to find solutions where others saw only obstacles. In 2002 U.S. Pres. George W. Bush asked Zerhouni to be the director of the NIH, the worldās largest medical research facility. The choice of Zerhouni came after months of searching for a candidate. Though closely grilled on the question of whether he would support the presidentās opposition to cloning and human embryonic stem cell research, Zerhouni managed to avoid making a definitive position statement. Shortly after the U.S. Senate confirmed his appointment as head of the NIH, Zerhouni called for more research to effect a āquantum leapā in medical discoveries, which he said was the most effective way to control the countryās ever-increasing health care costs. Zerhouni also helped create the Institute for Cell Engineering at Johns Hopkins. Researchers at the institute conducted pioneering embryonic stem cell research, with the goal of applying their knowledge to related work on adult stem cells, which the president endorsed. In October 2008 Zerhouni stepped down from his position as director of the NIH.
Zerhouni later joined the French pharmaceutical company Sanofi. From 2011 to 2018 he served as head of global research and development.